期刊名称：CURRENT NEUROPHARMACOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims & Scope
Current Neuropharmacology aims to provide current, timely and comprehensive reviews of all areas of neuropharmacology and related matters of neuroscience. The journal publishes reviews written by experts and leaders in the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.
The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.
Indexed in
Chemical Abstracts, EMBASE, PsycINFO, Science Citation Index Expanded (SciSearch?/FONT>), Journal Citation Reports/Science Edition, Neuroscience Citation Index?/FONT>, BIOSIS Reviews Reports and Meetings, BIOSIS Previews,
Instructions to Authors
Instructions for Authors
Correspondence should be submitted to the editorial office at the following address:
Professor Thomas E. Salt
Editor-in-Chief Current Neuropharmacology
Department of Visual Science
Institute of Ophthalmology
University College London
11-43 Bath Street
London EC1V 9EL
UK
Tel: +44 (0)20 7608 6843
Fax: + 44(0)20 7608 6912
E-mail: T.Salt@ucl.ac.uk
Unless invited to provide a review, it is preferable to send a brief outline of any text you propose to submit to the Editor-in-Chief by e-mail. The approximate date of submission of your review should also be included.
There is no specified word count for the reviews, however, the authors must cover a topic in detail (suggested length of the text is 20-30 A-4 pages that will convert to 15-20 pages in publication). All submitted manuscripts should be formatted to be double spaced throughout for the equivalent of either A-4 or US Letter (8.5x11 inches) paper.
Please note that all manuscripts should be submitted electronically (see below). Do not send the hard copies of manuscripts to the Editor-in-Chief.
Manuscript Organization: The manuscript should be divided as: Title page, abstract and the main text. The text may be subdivided further according to the areas to be discussed. This should be followed by the Acknowledgement (if any) and Reference sections. The first page should contain the title, the authors?names (initials and surname only), with an asterisk to mark the name of the principal author.
Conflict of Interest: Financial contributions to the work being reported should be clearly acknowledged, as should any potential conflict of interest.
Abstract: The abstract should not exceed 250 words and it should condense the essential features of the review article, with the focus on the major advances in the field.
Key Words: Authors must supply up to eight key words along with their manuscript.
Suggested Referees: Authors should suggest four reviewers who they consider to be qualified to referee the work and would not have a conflict of interest in reviewing the paper. Authors should include the complete address, phone and facsimile numbers, and email address for each potential referee. The actual selection of reviewers will be made by the Editor in Chief.
Text: The main text should begin on a separate page and it may be subdivided but not into the separate sections. The review article should mention any previous important reviews in the field and contain a comprehensive discussion starting with the general background of the field. It should then go on to discuss the salient features of recent developments. The authors should avoid presenting material that has already been published in a previous review. The reference numbers should be given in square brackets in the text. Acknowledgements should be kept to a minimum.
Tables:
- Data Tables should be submitted in Microsoft Excel or in Microsoft Word table format.
- Each table should include a title/caption explaining what the table shows. Detailed legends may then follow.
- Tables should be given on separate pages with indications on the left hand margin to the text, as to the appropriate placement of the tables.
- Tables should not contain vertical rules.
- Columns and rows of data should be made visibly distinct by ensuring the borders of each cell display as black lines.
- Tables should be numbered consecutively in order of their citation in the body of the text, with Arabic numerals.
- If a reference is cited in both the table and text, insert a lettered footnote in the table to refer to the numbered reference in the text.
- Tabular data provided as additional files can be submitted as an Excel spreadsheet.
Figures / Illustrations:
All authors must strictly follow the guidelines below for preparing illustrations for publication in Current Neuropharmacology.
Editorial Requirements:
The quality of the illustrations printed in the journal largely depends on the quality of the figures/illustration provided by the author. In preparing artwork or graphics for publication, keep in mind the following points.
- Submit the original artwork or a photographic print of the original for publication.
- Do not submit photocopies. (Hardcopy submission requirement).
- Illustrations should be provided as separate files, not embedded in the text. (Hardcopy submission requirement).
- Remove all color from graphics except for those illustrations (Greyscale), which are intended to be printed in color.
- Good quality of hardcopy originals are a requirement.
- Figures should be referred to as “Fig. (1)? “Fig. (2)?etc. in the text with figure numbers in bold within round bracket.
- Revised manuscripts should contain a complete set of artwork and photographs.
Technical Details:
- Figures should be provided on high quality, white, smooth opaque paper. (Hardcopy requirement).
Format & Resolution:
- The following file formats can be accepted. (Preference in order of appearance): PDF, TIFF, JPEG, GIF
- Illustrations must fit a single or double column format on the journal page, according to the following guideline below:
|
HEIGHT |
WIDTH |
|
SINGLE COLUMN |
24 cm (max) |
8.5 cm (max) |
|
DOUBLE COLUMN |
24 cm (max) |
18 cm (max) |
- Whenever possible, submit graphics that do not have to be reduced to fit the standard figure size.
- Use the best resolution available (hardcopy submission requirement). For online submission the maximum resolution is 300 dpi.
- Avoid textures and shadings giving a three-dimensional effect to the illustration.
- Symbols and lettering in the illustration should be of similar size.
- Smaller lettering is used.
- Font: Times New Roman or Helvetica is preferable. Font size: 10pt (maximum).
- Line drawings should have clear and sharp lines and should be of uniform density. Moreover, lines should be continuous without any breaks.
- Do not use lines thinner than 1 point.
Color Figures / Illustrations:
Chemical Structures: Structures should be presented separately, drawn using a suitable Graphics program (e.g. Chem. Draw). The structures should fit into a width of 8 cm (for structures to be inserted within single column widths) or a width of 18 cm (for structures or schemes to be inserted in double column widths).
References: The reference numbers should be given in square brackets in the text. All references must be complete and accurate. On-line citations should include date of access. Use of terminology "et al." must not be used. Journal title should conform to the present Index Medicus abbreviations.
References should be listed in the following style in alphabetical order:
Examples:
Typical Paper Reference:
[1] Watkins, J.C., Evans, R.H. (1981) Excitatory Amino Acid Transmitters. Ann. Rev. Pharmacol. Toxicol., 21, 165-204.
Typical Chapter Reference:
[1] Watkins, J.C. (1986) Twenty-five Years of Excitatory Amino Acid Research. In: Roberts, P.J., Storm-Mathisen, J., Bradford, H. Eds, Excitatory Amino Acids. Chichester, MacMillan Press. pp. 1-39.
Abstracts, unpublished data and personal communications (which can only be included if the permission has been obtained) should not be given in the reference section but they may be mentioned in the text with details provided as footnotes. All authors of referenced papers must be cited and there must be no use of the short hand version of et al. when citing the authors.
Manuscript Submission: Two copies of the manuscript must accompany the original along with the soft copy of the manuscript on a computer floppy disk(s) in MS Word file format (or created in any other well-known word processing software) should be submitted. To achieve rapid publication authors are encouraged to e-mail or fax their submission to the appropriate editorial office (see above) at the same time that they mail the manuscript. For even faster publication, authors are encouraged to submit their entire manuscript via Bentham’s online submission service (see below). Authors must provide their full address, telephone and Fax numbers with E-Mail address with all submissions.
For expedient and speedy reviewing of author's manuscripts, authors are strongly advised to include the PDF file of their manuscript on a floppy or zip disk, into the mailing material. At the same time the package is mailed, please also send by e-mail a copy of the PDF file of the manuscript to the editorial office.
Online Manuscript Submission: (preferable)
To facilitate speedy and cost-effective submission of abstracts and manuscripts, an online submission and tracking service via Internet is being offered. Once the Editor-in-Chief of the journal has accepted your abstract, we would prefer that you submit your full manuscript online via our online submission service available at www.bentham-mps.org
For online submission, please provide your complete manuscript in the form of a single zipped folder containing all the material (main text, figures/ illustrations, scanned photographs, tables, chemical structures drawn in ChemDraw) as separate files and a PDF version of the entire manuscript with all the figures/ illustrations / tables / chemical structures etc., embedded in the text exactly in the manner as they should appear in printing.
Authors are required to proofread the PDF version of their manuscript before submission. The article will be published exactly as received and the Publishers will not be responsible for any error occurring in the manuscript in this regard.
For online submission of manuscripts, these should be submitted via our online manuscript submission service available at www.bentham-mps.org or by FTP submission at www.bentham-ftp.org
You may, however, still submit your abstracts and manuscripts through conventional surface mail.
A successful electronic submission of a manuscript will be followed by a system-generated acknowledgement to the principal/corresponding author within 72 hours of the dispatch of the manuscript. Any queries therein should be addressed to mahmood@bentham.org and copied to Jalil@bentham.org
Page Charges: No page charges will be levied to authors.
Language Editing: Manuscripts submitted containing many English typographical errors will not be published. Authors from non-English language countries are advised to use the services of our professional language editing department prior to submitting their manuscript to the Journal. Please contact Bentham Publishing Services www.bentham.org/bps for a language editing quote at e-mail: bps@bentham.org stating the total number of words of the article to be edited.
Proofs: Authors are sent page proofs. To avoid delays in publication, proofs should be checked immediately for typographical errors and returned within 48 hours. Authors will be charged for excessive changes made at the page proof stage.
Reprints: Each first named author will receive by e-mail a free copy of their article as a PDF file. The PDF file is a watermarked version of the published article which is exclusively for the author's own use and may not be copied or distributed. Reprints may be ordered from the Publisher prior to publication of the article. First named authors may also order a personal print and online subscription of the journal at 50% off the normal subscription rate by contacting the subscription department at e-mail: subscriptions@bentham.org
Bentham Open Access: Accepted articles can be published online for an immediate free open access for all to view. Open access publishing provides the maximum dissemination of the article to the largest audience. Authors must pay for this service. For more information please contact us at e-mail: openaccess@bentham.org
Reviewing and Promptness of Publication: All papers submitted for publication will be immediately subjected to editorial scrutiny, usually in consultation with members of the Editorial Advisory Board. Every effort will be made to assess the papers quickly. The papers will be typeset and the proofs dispatched to the authors normally within 4 weeks of their acceptance.
Copyright: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
Editorial Board
Editor in Chief:
Thomas E. Salt,
Institute of Ophthalmology,
University College London,
London EC1V 9EL, England
Regional Editor (USA):
P. Jeffrey Conn, (Vanderbilt University Medical Center, Nashville TN, USA)
Regional Editor (Japan):
Nobuhisa Iwata (RIKEN Brain Science Institute, Saitama, Japan)
Editorial Advisory Board:
Bernhard Bettler (Physiologisches Institut, Basel, Switzerland)
Paolo Calabresi (Univ. Roma Tor Vergata, Rome, Italy)
MacDonald J. Christie (The Univ. of Sydney, Sydney, Australia)
Andre Dray (Astra Zeneca Res. & Devol., Montreal, Canada)
Christian C. Felder (Lilly Corporate Center, Indianapolis, IN, USA)
Raymond G. Hill (Merck Sharp & Dohme Res. Lab., Essex, UK)
Masanobu Kano (Kanazawa University, Kanazawa, Japan)
George Lees (University of Otago, Dunedin, New Zealand)
Mark J. Millan (Inst. de Rech. Servier, Croissy, Paris, France)
Flavio Moroni (Dipartimento di Farmacologia, Firenze, Italy)
Vincent Mutel (Addex Pharmaceuticals SA, Geneva, Switzerland)
Pradeep J. Nathan (Department of Physiology, Monash University, Australia)
Ferdinando Nicoletti (Univ. Rome"da Sapienza", Rome, Italy)
Michael A. Rogawski (Nat. Inst. Neuro. Disorders & Stroke, MD, USA)
Rod Scott (Aberdeen University, Aberdeen, UK)
Trevor Sharp (Univ. Department of Pharmacology, Oxford, UK)
David R. Sibley (Nat. Inst. of Neurological Dis. & Stroke, Bethesda, MD, USA)
Hiroshi Takeda (Tokyo Medical University, Tokyo, Japan)
Susan Wonnacott (University of Bath, Bath, UK)
|
刊名字顺( Alphabetical List of Journals):
返回页首 